#236: Expanded Access: Ethical, Regulatory, and Policy Challenges and Considerations
Chair
Vice President, Regulatory Affairs Americas, Bayer AG, United States
Kim Quaintance-Lunn is the Vice President, Regulatory Affairs Americas and a Distinguished Science Fellow at Bayer, a Director at Large for the FDA Alumni Association, and Chair of DIA's Americas Regional Advisory Council. At Bayer, Kim serves in a leadership capacity for US Regulatory...
Read More →
Speakers
Assistant Professor, Division of Medical Ethics, Dept of Population Health, NYU Grossman School of Medicine, United States
Alison Bateman-House, PhD, MPH, MA, is an assistant professor in the Division of Medical Ethics at NYU Grossman School of Medicine and a Professor of Practice in Law at University of Arizona James E. Rogers College of Law. She is co-chair of the Working Group on Compassionate Use...
Read More →
Vice President, Strategy Realization, Johnson & Johnson
Dr. Morris is currently VP, Strategy Realization for the J&J CMO. Prior to joining J&J, Dr. Morris spent 18 years at Merck where she was VP, Global Project Management. Dr. Morris received her PhD in Organic Chemistry and completed postdoctoral research in biochemistry.
Tuesday June 28, 2016 2:00pm - 3:15pm EDT
108B
Pennsylvania Convention Center 1101 Arch Street, Philadelphia, PA 19107 USA
Trk 02: Proj-Port Mgt-Strat Planning,
Session
- Credit Type ACPE, CME, IACET, RN
- Audience Intermediate
- Featured Topics Current Issues in Policy and Law, 21st Century Cures, Patient Engagement
- Interest Area Public Policy - Health Care Compliance - Law, Regulatory Affairs, Advertising & Promotion, Rare - Orphan Diseases, Patient Engagement
- format json
- Interest Area Public Policy / Health Care Compliance / Law,Regulatory Affairs,Advertising & Promotion,Rare / Orphan Diseases,Patient Engagement
- Featured Topics Current Issues in Policy and Law,21st Century Cures,Patient Engagement
- Credit Type ACPE, CME, IACET, RN
- Tags Session